Erste Group upgraded Vertex Pharmaceuticals (VRTX) to Buy from Hold. The firm expects the company to “develop positively in the coming quarters ...
Evercore ISI analyst Liisa Bayko maintained a Sell rating on AN2 Therapeutics, Inc. (ANTX – Research Report) yesterday and set a price target ...
Investing.com -- Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug ...
Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...